Author

Brandon J. Manley

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Risk-dependent Benefit of Adjuvant Pembrolizumab in High-risk Clear Cell Renal Cell Carcinoma: A Multi-institutional Study.

BACKGROUND Adjuvant pembrolizumab improves outcomes in high-risk clear cell renal cell carcinoma (ccRCC), but baseline recurrence risk varies substantially. OBJECTIVE To evaluate treatment selection, outcomes, toxicity, and risk-stratified benefit. DESIGN, SETTING, AND PARTICIPANTS A retrospective cohort of consecu...

D. D. Shapiro, D. Roadman, V. Master et al. · European Urology Oncology · 1 citation

#explainable ai Open access Sep 2026

67 Foundation Model Embeddings Identify Spatial Restructuring Associated with Immunotherapy Treatment Derived from Hemoxylin and Eosin Images

Interestingly, these preliminary findings suggest that general-purpose models from whole slide images, focusing primarily in the stroma, can be used to extract tissue characteristics that may be otherwise unrealized from H&E images.

Alex C. Soupir, S. Eschrich, Mitchell T. Hayes et al. · The Oncologist · 0 citations